Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Synata Bio

Synata Bio?uq=AFYHfsyn
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$47M LATEST DEAL AMOUNT
1 INVESTORS
Description

Provider of a technology platform designed to convert abundant feedstocks. The company's technology platform uses a single step low-cost process that converts a wide variety of abundant feedstocks, such as natural gas, biomass, industrial gases into drop-in fuels and chemicals and deploys a simple and novel technology for converting synthesis gas to products by combining proprietary biocatalysts with proven and scalable fermentation design, enabling users to get a platform with high carbon utilization and energy efficiency.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Commercial Services
Other Industries
Energy Production
Other Energy Services
Primary Office
  • 4575 Weaver Parkway
  • Suite 100
  • Warrenville, IL 60555
  • United States

+1 (312) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Synata Bio’s full profile, request a free trial.

Synata Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 30-Jan-2018 $47M 0000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Synata Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 000
To view this company’s complete Cap Table, request access »

Synata Bio Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000000 30-Nov-2016 000000000 00000 00 000.00 Buildings and Property 000000 00000
To view this company’s complete investment and acquisition history, request access »

Synata Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
True North Venture Partners Venture Capital Minority 000 0000 000000 0

Synata Bio Executive Team (1)

Name Title Board
Seat
Contact
Info
Steven Kloos President & Director

Synata Bio Board Members (3)

Name Representing Role Since Contact
Info
Jay Kouba Synata Bio Board Member 000 0000
Matthew Ahearn Synata Bio Board Member 000 0000
Steven Kloos Synata Bio President & Director 000 0000